CDMO Research and Charts

CDMO - Avid Bioservices Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-09-23 (Delayed quote data 2025-01-03)

Last 12.33	Change ⇑ +0.01 (+0.08%)	Volume 1,386,399
	Open 12.36	High 12.37	Low 12.32

8EMA (Daily) 12.31	40EMA (Daily) 12.02	50EMA (Daily) 11.88	STO (Daily) 66.849	MACD Hist (Daily) -0.063
8EMA (Weekly) 12.087	40EMA (Weekly) 10.47	50EMA (Weekly) 10.36	STO (Weekly) 95.009	MACD Hist (Weekly) 0.088


Company Profile
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.